Related Experiment Video

Updated: Aug 30, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma

Masood A Shammas1, Robert J Shmookler Reis, Masaharu Akiyama

  • 1Boston VA Health Care System, West Roxbury, MA, USA.

Molecular Cancer Therapeutics
|October 14, 2003
PubMed
Abstract

Insights

Tetra(N-methyl-4-pyridyl)-porphyrin chloride (TMPyP4) effectively inhibits telomerase activity in multiple myeloma cells, leading to significant cell death. This study highlights telomerase as a promising therapeutic target for multiple myeloma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Multiple myeloma exhibits high telomerase activity and shortened telomeres.
  • Telomerase is a key enzyme in cell proliferation and immortalization.

Purpose of the Study:

  • To evaluate the efficacy of tetra(N-methyl-4-pyridyl)-porphyrin chloride (TMPyP4) as a therapeutic agent for multiple myeloma.
  • To investigate the anti-proliferative effects of TMPyP4 on myeloma cells.

Main Methods:

  • Analysis of telomere length, telomerase activity, and gene expression in myeloma cell lines.
  • Treatment of myeloma cell lines (U266, ARH77, ARD) with TMPyP4.
  • Assessment of cell viability, apoptosis, and DNA fragmentation following TMPyP4 exposure.

Main Results:

  • TMPyP4 significantly inhibited telomerase activity in all tested myeloma cell lines (92-99% reduction).
  • Exposure to TMPyP4 led to a 75-90% decrease in viable myeloma cells within 4 weeks.
  • Cell death was confirmed to be apoptotic, involving caspase-3-activated DNase I.

Conclusions:

  • G-quadruplex-intercalating agents like TMPyP4 exhibit significant anti-proliferative activity against multiple myeloma.
  • Telomerase is a viable and important therapeutic target for the treatment of multiple myeloma.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...